|
LYSERGIC ACID
| | | | | |
|
Value
|
S.E.
|
df
|
t
|
P
| |
Intercept
|
0.960
|
0.067
|
106
|
14.355
|
0.001
|
***
|
Treat W
|
-0.117
|
0.059
|
37
|
-1.967
|
0.057
|
o
|
Treat N
|
0.084
|
0.059
|
37
|
1.427
|
0.162
| |
Orig G
|
0.005
|
0.067
|
106
|
0.073
|
0.941
| |
Orig S
|
0.051
|
0.067
|
106
|
0.762
|
0.448
| |
Orig KY31
|
-0.142
|
0.067
|
106
|
-2.106
|
0.038
|
*
|
AIC
|
102.17
| | | | | |
loglikelihood
|
-43.09
| | | | | |
|
LOLINES
| | | | | |
|
Value
|
S.E.
|
df
|
t
|
P
| |
Intercept
|
42.354
|
4.426
|
94
|
9.569
|
0.001
|
***
|
Treat W
|
11.330
|
6.963
|
36
|
1.627
|
0.112
| |
Treat N
|
4.341
|
6.109
|
36
|
0.711
|
0.482
| |
W*N
|
-7.556
|
9.161
|
36
|
-0.825
|
0.415
| |
Orig G
|
0.114
|
5.808
|
94
|
0.019
|
0.984
| |
Orig S
|
9.512
|
5.641
|
94
|
1.686
|
0.095
|
o
|
Orig KY31
|
-8.499
|
5.807
|
94
|
-1.463
|
0.147
| |
N*G
|
-0.066
|
8.652
|
94
|
-0.008
|
0.994
| |
N*S
|
-13.004
|
8.541
|
94
|
-1.523
|
0.131
| |
N*KY31
|
-4.916
|
8.652
|
94
|
-0.568
|
0.571
| |
W*G
|
-7.875
|
8.098
|
94
|
-0.972
|
0.333
| |
W*S
|
-20.203
|
8.125
|
94
|
-2.486
|
0.015
|
*
|
W*KY31
|
8.132
|
8.420
|
94
|
0.966
|
0.337
| |
N*W*G
|
-1.509
|
11.770
|
94
|
-0.128
|
0.898
| |
N*W*S
|
26.624
|
11.709
|
94
|
2.273
|
0.025
|
*
|
N*W*KY31
|
-8.947
|
11.916
|
94
|
-0.751
|
0.455
| |
AIC
|
1109.56
| | | | | |
loglikelihood
|
-536.78
| | | | | |